Drug
S55746 clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2015 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
Institut de Recherches Internationales Servier (2) · Novartis Pharmaceuticals (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses S55746 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin LymphomaCompletedPhase 1Institut de Recherches Internationales ServierNCT02920697Written as S 55746
- Study of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCLCompletedPhase 1Novartis PharmaceuticalsNCT02603445Written as BCL201
- Dose-escalation Study of Oral Administration of S 055746 in Patients With Acute Myeloid Leukaemia or Myelodysplastic SyndromeCompletedPhase 1Institut de Recherches Internationales ServierNCT02920541Written as S 055746